CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Sedation for Patients with Pneumonitis or Pneumonia Requiring Ventilation: Guidelines for Use

Last updated: August 17, 2009
Product Line: Rapid Response
Research Type: Drug
Result type: Report

Question

  1. What are the guidelines for choice and dosage of sedating agent for patients under 40 years of age with viral pneumonitis or pneumonia who require ventilation?
  2. What is the evidence that patients under 40 years with viral pneumonitis or pneumonia on ventilation require more sedating agent than other patients?